| __timestamp | MannKind Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100244000 | 31354781 |
| Thursday, January 1, 2015 | 29674000 | 43445817 |
| Friday, January 1, 2016 | 14917000 | 66489820 |
| Sunday, January 1, 2017 | 14118000 | 96886134 |
| Monday, January 1, 2018 | 8737000 | 153793000 |
| Tuesday, January 1, 2019 | 6900000 | 148369000 |
| Wednesday, January 1, 2020 | 6248000 | 151934000 |
| Friday, January 1, 2021 | 12312000 | 198532000 |
| Saturday, January 1, 2022 | 19721000 | 112128000 |
| Sunday, January 1, 2023 | 31283000 | 76192000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, TG Therapeutics, Inc. and MannKind Corporation have demonstrated contrasting trajectories in their R&D investments. TG Therapeutics has consistently increased its R&D spending, peaking in 2021 with a remarkable 530% increase from 2014. This surge underscores their commitment to advancing therapeutic solutions. In contrast, MannKind Corporation's R&D expenses have fluctuated, with a notable 69% decrease from 2014 to 2020, before a modest recovery in recent years. This divergence highlights the strategic differences between the two companies, with TG Therapeutics focusing on aggressive growth and MannKind adopting a more conservative approach. As the biotech landscape continues to shift, these trends offer valuable insights into the future directions of these industry leaders.
R&D Insights: How Novartis AG and MannKind Corporation Allocate Funds
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Summit Therapeutics Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and MannKind Corporation
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
R&D Insights: How Verona Pharma plc and MannKind Corporation Allocate Funds
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Research and Development Investment: Vericel Corporation vs MannKind Corporation
Iovance Biotherapeutics, Inc. or MannKind Corporation: Who Invests More in Innovation?
R&D Insights: How MannKind Corporation and Taro Pharmaceutical Industries Ltd. Allocate Funds